Da Wo

634 total citations
32 papers, 393 citations indexed

About

Da Wo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Da Wo has authored 32 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cancer Research. Recurrent topics in Da Wo's work include Wnt/β-catenin signaling in development and cancer (7 papers), Cardiac Fibrosis and Remodeling (6 papers) and Signaling Pathways in Disease (5 papers). Da Wo is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (7 papers), Cardiac Fibrosis and Remodeling (6 papers) and Signaling Pathways in Disease (5 papers). Da Wo collaborates with scholars based in China, Japan and United Kingdom. Da Wo's co-authors include Dan‐ni Ren, Weidong Zhu, Jingxiao Chen, Jun Peng, Hongwei Yan, Shangfeng Liu, Jing Hua, Jianfeng Chu, Yong Fang and Yan Yin and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Da Wo

29 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Da Wo China 12 203 58 49 47 34 32 393
Lu Wu China 11 224 1.1× 84 1.4× 33 0.7× 65 1.4× 18 0.5× 29 420
Fanhua Meng China 11 132 0.7× 38 0.7× 21 0.4× 24 0.5× 45 1.3× 32 416
Qingsheng You China 17 303 1.5× 94 1.6× 39 0.8× 99 2.1× 20 0.6× 38 632
Ju‐Ryoung Kim South Korea 11 306 1.5× 39 0.7× 40 0.8× 68 1.4× 7 0.2× 19 550
Chunlin Li China 10 217 1.1× 52 0.9× 44 0.9× 34 0.7× 7 0.2× 20 394
Wenqiang Liao China 14 252 1.2× 78 1.3× 67 1.4× 64 1.4× 46 1.4× 34 551
Shanshan Hu China 15 341 1.7× 52 0.9× 28 0.6× 34 0.7× 9 0.3× 31 535

Countries citing papers authored by Da Wo

Since Specialization
Citations

This map shows the geographic impact of Da Wo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Wo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Wo more than expected).

Fields of papers citing papers by Da Wo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da Wo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Wo. The network helps show where Da Wo may publish in the future.

Co-authorship network of co-authors of Da Wo

This figure shows the co-authorship network connecting the top 25 collaborators of Da Wo. A scholar is included among the top collaborators of Da Wo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da Wo. Da Wo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Xinxin, et al.. (2025). Baicalin Prevents Chronic β‐AR Agonist‐Induced Heart Failure via Preventing Oxidative Stress and Overactivation of the NADPH Oxidase NOX2. Journal of Cellular and Molecular Medicine. 29(4). e70388–e70388. 2 indexed citations
3.
Gong, Yuhang, Da Wo, Canran Wang, et al.. (2025). Qingda granule prevents Ang II-induced cardiac hypertrophy via inhibiting NF-κB signaling pathway. Frontiers in Pharmacology. 16. 1603316–1603316. 1 indexed citations
4.
Wo, Da, Jingxiao Chen, Xiaohui Zhou, et al.. (2023). Inhibition of a novel Dickkopf-1-LDL receptor–related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice. European Heart Journal. 45(9). 688–703. 8 indexed citations
5.
Chen, Jingxiao, et al.. (2023). Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling. Biomedicine & Pharmacotherapy. 165. 115275–115275. 24 indexed citations
6.
Zhong, Xiaomei, et al.. (2023). Liensinine prevents ischemic injury following myocardial infarction via inhibition of Wnt/β‑catenin signaling activation. Biomedicine & Pharmacotherapy. 162. 114675–114675. 7 indexed citations
8.
Gao, Qian, E. Ma, Jingxiao Chen, et al.. (2022). Qingda granule prevents obesity-induced hypertension and cardiac dysfunction by inhibiting adverse Akt signaling activation. Heliyon. 8(12). e12099–e12099. 5 indexed citations
9.
Wo, Da, Jingxiao Chen, Qiongyu Li, et al.. (2020). IGFBP‐4 enhances VEGF‐induced angiogenesis in a mouse model of myocardial infarction. Journal of Cellular and Molecular Medicine. 24(16). 9466–9471. 8 indexed citations
10.
Chen, Jingxiao, Da Wo, Hongwei Yan, et al.. (2019). LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung. Clinical Cancer Research. 25(15). 4832–4845. 22 indexed citations
11.
Li, Qiongyu, Da Wo, Yue Huang, et al.. (2019). Alkaloids from Nelumbinis Plumula (AFNP) ameliorate aortic remodeling via RhoA/ROCK pathway. Biomedicine & Pharmacotherapy. 112. 108651–108651. 20 indexed citations
12.
Chen, Jingxiao, Da Wo, Hongwei Yan, et al.. (2019). Deletion of low-density lipoprotein-related receptor 5 inhibits liver Cancer cell proliferation via destabilizing Nucleoporin 37. Cell Communication and Signaling. 17(1). 174–174. 30 indexed citations
13.
Hua, Jing, Li Zhu, Li Du, et al.. (2018). Effects of midwife-led maternity services on postpartum wellbeing and clinical outcomes in primiparous women under China’s one-child policy. BMC Pregnancy and Childbirth. 18(1). 329–329. 16 indexed citations
14.
Qiu, Liman, Jingxiao Chen, Lin Jing, et al.. (2017). Baicalin alleviates H2O2-induced injury of H9c2 cardiomyocytes through suppression of the Wnt/β-catenin signaling pathway. Molecular Medicine Reports. 16(6). 9251–9255. 24 indexed citations
15.
Hua, Jing, Guixiong Gu, Qingqing Zhu, et al.. (2015). The reliability and validity of the Developmental Coordination Disorder Questionnaire’07 for children aged 4–6 years in mainland China. Research in Developmental Disabilities. 47. 405–415. 16 indexed citations
16.
Wo, Da, et al.. (2015). Free Radicals, the Natural Antioxidant Buyang Huanwu Decoction and Ischemic Stroke. 1(4). 183–187. 1 indexed citations
17.
He, Qingqing, Hongwei Yan, Da Wo, et al.. (2015). Wnt3a suppresses Wnt/β-catenin signaling and cancer cell proliferation following serum deprivation. Experimental Cell Research. 341(1). 32–41. 8 indexed citations
18.
Wu, Jianye, et al.. (2015). Risks and predictors of mild diastolic dysfunction among middle-aged and aged women: a population-based cohort study. Journal of Human Hypertension. 30(5). 335–340. 9 indexed citations
19.
Chen, Jingxiao, Hongwei Yan, Dan‐ni Ren, et al.. (2014). LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation. Cellular Signalling. 26(5). 1068–1074. 31 indexed citations
20.
Wo, Da, et al.. (2013). A novel spectrophotometric method for indirect determination of nitric oxide (NO) in serum. Clinica Chimica Acta. 424. 187–190. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026